A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 Gangliosidoses, and Ataxia Telangiectasia
T. Fields, M. Patterson, T. Bremova, G. Belcher, I. Billington, G.C. Churchill, W. Davis, W. Evans, S. Flint, A. Galione, U. Granzer, J. Greenfield, R. Karl, R. Kay, D. Lewi, T. Mathieson, T. Meyer, D. Pangonis, F.M. Platt, L. Tsang, C. Verburg, M. Factor, M. Strupp
medRxiv 2020.03.11.20034256; doi: https://doi.org/10.1101/2020.03.11.20034256
